EBD Group is part of the KNect365 of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy Partnerships in Cell and Gene Therapy
Share/Follow Us
Share this:
Follow this event:
Subscribe to our newsletters:

Videos


Interview: Abeona breaking into rare diseases Interview: Abeona breaking into rare diseasesJanuary 11, 2016Abeona Therapeutics' President and CEO tells Mike Ward how his company is poised to enter the clinic with its lead gene therapy programs targeting some devastating lysosomal diseases. View session here View session here
Cell-based therapies for cancer Cell-based therapies for cancerNovember 2, 2015With all of the exciting developments in cell-based therapies for cancer, this session gets past the hype to discuss the practical issues necessary for the promises of treatments to become reality. View session here View session here
Interview with Sarah Frew, University of Pennsylvania Interview with Sarah Frew, University of PennsylvaniaSeptember 16, 2015Formerly with Genzyme and Tetralogic, U. Penn’s Sarah Frew talked about opportunities for technology transfer from academic research to the private sector. View session here View session here
The evolution of the Regen Med ecosystem: What's required for its growth and sustainability? The evolution of the Regen Med ecosystem: What's required for its growth and sustainability?September 17, 2015Panelists discuss the need for an integrated approach to building the necessary infrastructure for success in innovative biotech and regenerative medicine. View session here View session here
Genome editing Genome editingSeptember 17, 2015We have seen exciting progress in the field of gene editing, but how are these advances being applied to cell therapy and disease modification? View session here View session here
Gene and cell therapy
Gene and cell therapy September 17, 2015Gene therapy is transforming the way we treat diseases. This panel discusses the latest industry advances, including new partnerships and regulatory issues. View session here View session here
Opportunities for regenerative medicine in Japan Opportunities for regenerative medicine in Japan3/9/2015Creating new businesses for highly advanced technologies can be challenging. Esaki addresses ways to encourage the development of new life science technologies amid current restraints. View session here View session here
Next generation treatments in ophthalmology: Can gene and cell-based therapies meet growing expectations for early clinical success? Next generation treatments in ophthalmology: Can gene and cell-based therapies meet growing expectations for early clinical success?3/9/2015Many experts predict that some of the early clinical successes in cell and gene therapy will be for ophthalmological indications such as retinitis pigmentosa, AMD, and glaucoma. View session here View session here
Undermining metastases and preventing recurrence: Therapeutics targeting cancer stem cells Undermining metastases and preventing recurrence: Therapeutics targeting cancer stem cells3/9/2015This panel discusses the ideas underlying unique cancer cell populations, the various strategies being pursued to develop therapies against them, and their clinical development paths. View session here View session here
Arrow Up

Follow this event:
Home | Contact Us | Site Map
See more upcoming conferences ►

EBD Group's Family of Events

© 2009–2016 EBD Group
Privacy Policy and Cookies
Terms of Use